Research

Hormonal

In adolescent girls with PCOS, hyperandrogenemia (specifically elevated bioavailable testosterone) is an independent risk factor for metabolic syndrome, increasing the odds of MBS by approximately 4-fold per quartile of testosterone after adjusting for obesity and insulin resistance.

For adolescent girls with PCOS, high testosterone levels are a direct driver of metabolic syndrome risk, separate from how much they weigh. This means that even if a patient is not obese, high androgens can still put them at risk for metabolic issues. Treatment strategies should consider targeting androgen levels, not just weight.

GoodSupportsHIGH confidence
The odds of having the MBS were 3.8 times higher for every quartile increase in bioavailable testosterone in girls with PCOS after adjusting for BMI and insulin resistance (odds ratio, 3.8; 95% confidence interval, 1.4 – 10.2; P (cid:2) 0.008).
Andrea D. Coviello et al. · The Journal of Clinical Endocrinology & Metabolism · 2006

Why this rating

Cross-sectional case-control study with a clear comparison group (NHANES III) and robust statistical adjustment for confounders (BMI, IR).

Source

Adolescent Girls with Polycystic Ovary Syndrome Have an Increased Risk of the Metabolic Syndrome Associated with Increasing Androgen Levels Independent of Obesity and Insulin Resistance

Andrea D. Coviello et al. · The Journal of Clinical Endocrinology & Metabolism · 2006

DOI 10.1210/jc.2005-1666

cross_sectional · n=214Cited 452×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →